Cardiac diastolic dysfunction predicts poor prognosis in patients with decompensated liver cirrhosis
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: Left ventricular diastolic dysfunction (LVDD) is an early manifestation of cardiac dysfunction in patients with liver cirrhosis (LC). However, the effect of LVDD on survival has not been clarified, especially in decompensated LC. Methods: We prospectively enrolled 70 patients with decompensated LC, including ascites or variceal bleeding, at Daejeon St. Mary’s Hospital from April 2013 to April 2015. The cardiac function of these patients was evaluated using 2D echocardiography with tissue Doppler imaging. The diagnosis of LVDD was based on the American Society of Echocardiography guidelines. The primary endpoint was overall survival. Results: Forty-four patients (62.9%) had LVDD. During follow-up (22.3 months), 18 patients died (16 with LVDD and 2 without LVDD). The survival rate was significantly lower in patients with LVDD than in those without LVDD (31.1 months vs. 42.6 months, P=0.01). In a multivariate analysis, the Child-Pugh score and LVDD were independent predictors of survival. Moreover, patients with a ratio of early filling velocity to early diastolic mitral annular velocity (E/e’) ≥ 10 (LVDD grade 2) had lower survival than patients with E/e’ ratio < 10. Conclusions: The presence of LVDD is associated with poor survival in patients with decompensated LC. Therefore, it may be important to monitor and closely follow LVDD patients.
Abstract
Background/Aims: Left ventricular diastolic dysfunction (LVDD) is an early manifestation of cardiac dysfunction in patients with liver cirrhosis (LC). However, the effect of LVDD on survival has not been clarified, especially in decompensated LC. Methods: We prospectively enrolled 70 patients with decompensated LC, including ascites or variceal bleeding, at Daejeon St. Mary’s Hospital from April 2013 to April 2015. The cardiac function of these patients was evaluated using 2D echocardiography with tissue Doppler imaging. The diagnosis of LVDD was based on the American Society of Echocardiography guidelines. The primary endpoint was overall survival. Results: Forty-four patients (62.9%) had LVDD. During follow-up (22.3 months), 18 patients died (16 with LVDD and 2 without LVDD). The survival rate was significantly lower in patients with LVDD than in those without LVDD (31.1 months vs. 42.6 months, P=0.01). In a multivariate analysis, the Child-Pugh score and LVDD were independent predictors of survival. Moreover, patients with a ratio of early filling velocity to early diastolic mitral annular velocity (E/e’) ≥ 10 (LVDD grade 2) had lower survival than patients with E/e’ ratio < 10. Conclusions: The presence of LVDD is associated with poor survival in patients with decompensated LC. Therefore, it may be important to monitor and closely follow LVDD patients.
참고문헌 (26)
- Lim YS, "The global impact of hepatic fibrosis and endstage liver disease", Clin Liver Dis, 12, pp.733~746 (2008)
- Ge PS, "The changing role of beta-blocker therapy in patients with cirrhosis", J Hepatol, 60, pp.643~653 (2014)
- Jepsen P, "The clinical course of cirrhosis : the importance of multistate models and competing risks analysis", Hepatology, 62, pp.292~302 (2015)
- Timoh T, "A perspective on cirrhotic cardiomyopathy", Transplant Proc, 43, pp.1649~1653 (2011)
- Krag A, "The window hypothesis : haemodynamic and non-haemodynamic effects of β-blockers improve survival of patients with cirrhosis during a window in the disease", Gut, 61, pp.967~969 (2012)
- Carvalheiro F, "Diastolic dysfunction in liver cirrhosis: prognostic predictor in liver transplantation?", Transplant Proc, 48, pp.128~131 (2016)
- Ruiz-del-Árbol L, "Cirrhotic cardiomyopathy", World J Gastroenterol, 21, pp.11502~11521 (2015)
- Fede G, "Cardiovascular dysfunction in patients with liver cirrhosis", Ann Gastroenterol, 28, pp.31~40 (2015)
- Wiese S, "Cirrhotic cardiomyopathy : pathogenesis and clinical relevance", Nat Rev Gastroenterol Hepatol, 11, pp.177~186 (2014)
- Falletta C, "Diastolic dysfunction diagnosed by tissue Doppler imaging in cirrhotic patients : prevalence and its possible relationship with clinical outcome", Eur J Intern Med, 26, pp.830~834 (2015)
- Nagueh SF, "Recommendations for the evaluation of left ventricular diastolic function by echocardiography", J Am Soc Echocardiogr, 22, pp.107~133 (2009)
- Nagueh SF, "Recommendations for the evaluation of left ventricular diastolic function by echocardiography : an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging", J Am Soc Echocardiogr, 29, pp.277~314 (2016)
- Møller S, "Diastolic dysfunction in cirrhosis", Heart Fail Rev, 21, pp.599~610 (2016)
- Møller S, "Cirrhotic cardiomyopathy : a pathophysiological review of circulatory dysfunction in liver disease", Heart, 87, pp.9~15 (2002)
- Pugh RN, "Transection of the oesophagus for bleeding oesophageal varices", Br J Surg, 60, pp.646~649 (1973)
- Karagiannakis DS, "Diastolic cardiac dysfunction is a predictor of dismal prognosis in patients with liver cirrhosis", Hepatol Int, 8, pp.588~594 (2014)
- Kwon JH, "The usefulness of C-reactive protein and neutrophil-to-lymphocyte ratio for predicting the outcome in hospitalized patients with liver cirrhosis", BMC Gastroenterol, 15, pp.146~ (2015)
- Di Martino V, "Prognostic value of C-reactive protein levels in patients with cirrhosis", Liver Transpl, 21, pp.753~760 (2015)
- Bernardi M, "Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors", Hepatology, 27, pp.28~34 (1998)
- Puthumana L, "Prolonged QTc interval and its relationship to autonomic cardiovascular reflexes in patients with cirrhosis", J Hepatol, 35, pp.733~738 (2001)
- Bernardi M, "QT interval prolongation in liver cirrhosis: innocent bystander or serious threat?", Expert Rev Gastroenterol Hepatol, 6, pp.57~66 (2012)
- Henriksen JH, "Increased circulating pro-brain natriuretic peptide (proBNP)and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease", Gut, 52, pp.1511~1517 (2003)
- Pimenta J, "B-type natriuretic peptide is related to cardiac function and prognosis in hospitalized patients with decompensated cirrhosis", Liver Int, 30, pp.1059~1066 (2010)
- Shi LY, "B-type natriuretic peptide and cirrhosis progression", Genet Mol Res, 14, pp.5188~5196 (2015)
- 하종원, "Therapeutic Strategies for Diastolic Dysfunction: A Clinical Perspective", Journal of Cardiovascular Imaging, 17(3), pp.86~95 (2009), 한국심초음파학회
- Ruíz-del-Árbol L, "Diastolic dysfunction is a predictor of poor outcomes in patients with cirrhosis, portal hypertension, and a normal creatinine", Hepatology, 58, pp.1732~1741 (2013)